Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Mirador Capital Partners LP

Mirador Capital Partners LP grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 3,526 shares of the medical equipment provider’s stock after buying an additional 50 shares during the quarter. Mirador Capital Partners LP’s holdings in Intuitive Surgical were worth $1,732,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the business. J. W. Coons Advisors LLC increased its holdings in Intuitive Surgical by 6.0% during the 4th quarter. J. W. Coons Advisors LLC now owns 1,170 shares of the medical equipment provider’s stock valued at $395,000 after acquiring an additional 66 shares in the last quarter. Oppenheimer & Co. Inc. grew its position in shares of Intuitive Surgical by 13.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 13,902 shares of the medical equipment provider’s stock valued at $4,690,000 after purchasing an additional 1,597 shares during the period. Cetera Advisor Networks LLC lifted its holdings in shares of Intuitive Surgical by 22.7% during the 4th quarter. Cetera Advisor Networks LLC now owns 35,285 shares of the medical equipment provider’s stock worth $11,904,000 after acquiring an additional 6,517 shares during the period. Envestnet Asset Management Inc. boosted its position in shares of Intuitive Surgical by 17.2% in the fourth quarter. Envestnet Asset Management Inc. now owns 628,630 shares of the medical equipment provider’s stock worth $212,075,000 after acquiring an additional 92,262 shares during the last quarter. Finally, Morningstar Investment Services LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $499,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 1,413 shares of the firm’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,414,931.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 1,413 shares of the stock in a transaction on Friday, July 26th. The stock was sold at an average price of $438.60, for a total transaction of $619,741.80. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,414,931.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares in the company, valued at $402,519.88. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 53,120 shares of company stock worth $25,528,753 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock traded up $2.32 on Friday, reaching $481.95. The company’s stock had a trading volume of 903,893 shares, compared to its average volume of 1,479,332. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $496.48. The company has a market capitalization of $170.95 billion, a P/E ratio of 86.99, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. The firm has a fifty day moving average of $476.55 and a two-hundred day moving average of $431.54.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the prior year, the business posted $1.18 earnings per share. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ISRG shares. BTIG Research increased their price target on shares of Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a research note on Wednesday, August 28th. Morgan Stanley boosted their price target on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price target for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Citigroup lifted their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Piper Sandler raised their price target on shares of Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $449.70.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.